Paul Thomas is a director of Axogen Inc.
Person profile
Latest filings (excl ownership)
No filings
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
1 Sep 23 | AXGN Axogen | RSU Common Stock | Grant | Acquire A | No | No | 0 | 11,904 | 0.00 | 11,904 |
1 Sep 23 | AXGN Axogen | Employee Stock Option (right to purchase) Common Stock | Grant | Acquire A | No | No | 6.3 | 20,436 | 128.75 k | 20,436 |
1 Jun 23 | AXGN Axogen | Common Stock | Option exercise | Acquire M | No | No | 0 | 6,459 | 0.00 | 9,495 |
1 Jun 23 | AXGN Axogen | RSU Common Stock | Option exercise | Dispose M | No | No | 0 | 6,459 | 0.00 | 0 |
22 Dec 22 | ABMD Abiomed | Common Stock, $.01 par value | Sale back to company | Dispose D | No | No | 0 | 6,357 | 0.00 | 0 |
1 Nov 22 | ABMD Abiomed | Common Stock, $.01 par value | Sell | Dispose S | No | Yes | 379.38 | 1,000 | 379.38 k | 6,357 |